A therapy system includes a patient support apparatus and a pneumatic therapy device that is coupleable to the patient support apparatus. The therapy device may receive power and air flow from the patient support apparatus.

The invention relates to a method and apparatus for diagnosis, performance and/or regulation of physiological functions, in particular in an anaesthetized patient. The apparatus has a pressure device (10) for at least one body region or extremity (55) of a patient (50), wherein pressure-increasing means (21) and pressure-reducing means (22) are assigned to the pressure device (10), and a control device (30) is provided with which the pressure in the pressure device (10) can be controlled via the pressure-increasing means (21) and the pressure-reducing means (22).

The pneumatic therapy apparatus and method with overlapped compression include a wrap and a controller. The wrap includes an outer wrap and an inner air bladder set; the controller can be fixedly connected to, detachably connected to, or separately connected to the outer wrap; the inner air bladder set includes one or more than one set of a first air bladder and a second air bladder that are overlapped; the controller contains an inflating motor and an integrated control board that are electrically connected. The inflating motor that is controlled by the integrated control board inflates the second air bladder first and then the first air bladder to achieve the overlapped compression between the second air bladder and the first air bladder. Therefore, the user can use the pneumatic therapy apparatus and method with overlapped compression to promote blood flow, treat lymphedema, prevent deep vein thrombosis and other diseases, and improve user experience in the treatment areas.

Monitoring vital parameters of a wearer of a compression garment by analyzing a pressure signal waveform indicative of a fluid pressure in an inflatable and deflatable bladder of the compression garment. Analyzing the pressure signal waveform for an oscillating amplitude as a function of time and/or a representation of a pulse of the wearer provides an indication of blood pressure of the wearer.

Methods and apparatuses for dispersing a compound within the patient are described. In one embodiment, an effective amount of a compound may be present in the cerebrospinal fluid of a patient and a force may be applied to the torso of the patient sufficient to enhance the convection of the cerebrospinal fluid. In another embodiment, a bolus including a compound may be injected into the cerebrospinal fluid of a patient. The volume of the bolus may be between about 5% and 30% of the total volume of the cerebrospinal fluid of the patient.

A device (900) includes a leg engaging section (101) and a foot engaging section (102 intersecting at a heel receiver (103). The leg engaging section and the foot engaging section defining a leg insertion aperture (104). A first compression wrap member (301) and a second compression wrap member (302) extend from the leg engaging section. An inflatable bladder (501) can be disposed along the leg engaging section between the leg insertion aperture and a compressible cushion layer (902). The inflatable bladder can be selectively inflatable through a connection tube (502) exiting the inflatable bladder at a non-orthogonal angle (504) relative to an edge (507) of the inflatable bladder. The leg engaging section can define at least one channel (1002) to permit the connection tube to exit the device.

A composition, method and related systems for treating and/or preventing spasticity in a patient using negative pressure therapy. The negative pressure therapy may include intermittent application of negative pressure to a limb or portion of a body, such as alternating between periods of negative pressure and ambient pressure. The negative pressure therapy may be applied on a regular basis for a predetermined period, such that an effective amount of negative pressure for treating spasticity and other symptoms of neurogenerative diseases is administered. The negative pressure therapy may be applied to cause intermittent activation of the venous arterial reflex in the body for a sustained period, such that symptoms of neurogenerative diseases are alleviated or prevented.

Disclosed is ischemic precondition treatment equipment and a use and method thereof for judging health condition of blood vessels. A gas way structure (4) is arranged inside a shell of ischemic precondition training treatment equipment. The gas way structure comprises a 5-way device (43). The 5-way device (43) is connected to a left gas pump (41), a right gas pump (42), a left solenoid valve (44), a right solenoid valve (45) and a release valve (48), respectively. The gas way structure (4) can rapidly bring a pressure of an armband airbag to the set pressure value in a short period of time, which is effective in relieving the patients' discomfort and pain when used. It is suitable for long-term use for training. In addition, it also can judge the health condition of blood vessels.

A pneumatic compression assembly that includes a sleeve having an outer layer and an inner layer that defines a sleeve interior configured to receive a body part of a user, and at least a first vibration assembly configured to provide vibration to the body part of the user. A plurality of inflatable compartments are arranged longitudinally along the sleeve between the inner layer and the outer layer. The first vibration assembly includes a plurality of vibration motors positioned between the inner layer and the outer layer of the sleeve.

A method and device that provides an improved way to treat lymphedema. An ultrasonic fluid pump including speakers attached to a flexible material stocking, combined with a controller, which is adapted to control the operation of the speakers to enable the speakers to cause fluid to flow in a predetermined direction.